Literature DB >> 8570522

Precipitation of insulinotropin in the presence of protamine: effect of phenol and zinc on the isophane ratio and the insulinotropin concentration in the supernatant.

Y Kim1, C A Rose.   

Abstract

PURPOSE: The purpose of this study is to determine the minimum quantity of protamine required for the completion of insulinotropin precipitation under different precipitation conditions.
METHODS: The experiments involved combining insulinotropin with varying concentrations of protamine in pH 7.2 phosphate buffered saline and analyzing the concentrations of both proteins in the supernatant. Isophane ratio (the protamine/insulinotropin molar ratio that results in a minimum total protein concentration in the supernatant) was determined for different precipitation conditions.
RESULTS: When neutral solutions of insulinotropin (pI 5.3) and protamine (pI 13.8) were combined, precipitation did not occur. However, in the presence of phenol and/or zinc, insulinotropin co-precipitated with protamine. In the presence of phenol, the isophane ratio and the insulinotropin concentration in the supernatant were determined to be 0.08 and 0.18 mg/ml, respectively. In the presence of zinc, the isophane ratio increased with zinc concentration, apparently from the precipitation of protamine in the presence of zinc. The isophane ratio and the insulinotropin concentration in the supernatant were 0.13 and 0.13 mg/ml, respectively, when the zinc/insulinotropin molar ratio was one. In the presence of phenol and zinc with the zinc/insulinotropin molar ratio of 1.0, the isophane ratio and the insulinotropin concentration in the supernatant were 0.11 and 1 microgram/ml, respectively.
CONCLUSIONS: A method to determine the isophane ratio of protamine/insulinotropin precipitation was developed to determine the minimum quantity of protamine required for the completion of insulinotropin precipitation under different precipitation conditions. A synergistic effect between phenol and zinc on the precipitation of insulinotropin in the presence of protamine was found.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570522     DOI: 10.1023/a:1016209304172

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Some investigations on the absorption mechanism of protamine insulin.

Authors:  H O BANG
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1946

2.  Frequency and specificity of protamine antibodies in diabetic and control subjects.

Authors:  L J Nell; J W Thomas
Journal:  Diabetes       Date:  1988-02       Impact factor: 9.461

3.  Mutations in the guinea pig preproglucagon gene are restricted to a specific portion of the prohormone sequence.

Authors:  S Seino; M Welsh; G I Bell; S J Chan; D F Steiner
Journal:  FEBS Lett       Date:  1986-07-14       Impact factor: 4.124

4.  Protamine as a cause of generalised allergic reactions to NPH insulin.

Authors:  M B Sánchez; M Paolillo; R S Chacón; M Camejo
Journal:  Lancet       Date:  1982-05-29       Impact factor: 79.321

5.  Sustained effect of zinc-protamin-glucagon in hyperlipidaemic patients.

Authors:  J Buch; A Buch
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1983-09

6.  Inhibitory effect of glucagon on erythropoiesis.

Authors:  J P Naets; M Guns
Journal:  Blood       Date:  1980-06       Impact factor: 22.113

7.  Mammalian pancreatic preproglucagon contains three glucagon-related peptides.

Authors:  L C Lopez; M L Frazier; C J Su; A Kumar; G F Saunders
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

8.  Hamster preproglucagon contains the sequence of glucagon and two related peptides.

Authors:  G I Bell; R F Santerre; G T Mullenbach
Journal:  Nature       Date:  1983-04-21       Impact factor: 49.962

Review 9.  Protamine: a review of its toxicity.

Authors:  J C Horrow
Journal:  Anesth Analg       Date:  1985-03       Impact factor: 5.108

10.  Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.

Authors:  J Brange; L Langkjaer
Journal:  Acta Pharm Nord       Date:  1992
View more
  2 in total

1.  Effects of non-covalent self-association on the subcutaneous absorption of a therapeutic peptide.

Authors:  D K Clodfelter; A H Pekar; D M Rebhun; K A Destrampe; H A Havel; S R Myers; M L Brader
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

2.  The application of crystal soaking technique to study the effect of zinc and cresol on insulinotropin crystals grown from a saline solution.

Authors:  Y Kim; A M Haren
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.